Healthcare

Updated 04/11/2025

Kurma Partners, a member of the Eurazeo group and founding investor of ImCheck Therapeutics, announces the sale of the biotech company to Ipsen for up to €1 billion

Share on

IMCheck_SITE_HOME.jpg
22/10/2025 - min

Information - Individual investors

Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)

LEARN MORE